The effects of three non-steroidal anti-inflammatory drugs, ibufenac, sulindac and mepirizole, on the renal excretion of sulfamethizole in rats were investigated, in order to clarify the mechanisms involved. The clearance ratio of sulfamethizole was markedly decreased after infusion of ibufenac, while sulindac or mepirizole had no effect on the clearance ratio of sulfamethizole. From this result, it is speculated that the decrease of renal excretion of sulfamethizole caused by ibufenac is mainly due to competitive interaction between sulfamethizole and ibufenac at the renal secretory level. The correlation between the chemical structures of some anionic non-steroidal anti-inflammatory drugs and the characteristics of renal tubular transport is discussed.
(Received March 16, 1987) The effects of three non-steroidal anti-inflammatory drugs, ibufenac, sulindac and mepirizole, on the renal excretion of sulfamethizole in rats were investigated, in order to clarify the mechanisms involved. The clearance ratio of sulfamethizole was markedly decreased after infusion of ibufenac, while sulindac or mepirizole had no effect on the clearance ratio of sulfamethizole. From this result, it is speculated that the decrease of renal excretion of sulfamethizole caused by ibufenac is mainly due to competitive interaction between sulfamethizole and ibufenac at the renal secretory level. The correlation between the chemical structures of some anionic non-steroidal anti-inflammatory drugs and the characteristics of renal tubular transport is discussed. Many drugs are excreted by renal tubular secretion. It is well known that p-aminohippurate (PAH) inhibits the tubular secretion of penicillin, and this interaction had been used therapeutically.1) Probenecid inhibits the renal clearance of indomethacin and this interaction is also probably clinically significant2) Thus, in considering pharmacokinetic drug interactions, we must take mutual interactions during renal excretion into account.
Recently, many new non-steroidal anti-inflammatory (NSAI) drugs have been introduced clinically for the therapy of various diseases. These NSAI drugs are frequently coadministered with various chemotherapeutic drugs, and pharmacokinetic drug interactions in such drug combinations must be taken into account in establishing dosage schedules.
We have already reported pharmacokinetic drug interactions between sulfamethizole and nine NSAI drugs at the renal level in rats. [3] [4] [5] [6] In this paper, we deal with the interactions between sulfamethizole (SMZ) and ibufenac, sulindac or mepirizole at the renal level in rats, examined by the renal clearance technique. Furthermore, the correlation between the chemical structures of some NSAI drugs and the characteristics of the renal tubular transport is discussed. Table   I .10) As shown in Fig. 1 and Table I , a marked decline in the clearance ratio of SMZ was observed after ibufenac infusion. However, SMZ excretion was not affected by sulindac or mepirizole at the dosage level of this experiment, as shown in Fig. 1 There was a marked difference in the clearance ratio of SMZ before and after ibufenac infusion, as shown in Fig. 1 . This result indicates that renal tubular secretion of SMZ might be decreased by competition with ibufenac for the same transport process. The result for ibufenac is in agreement with previous results obtained for chemically analogous NSAI drugs such as 4-biphenylacetic acids ) and diclofenac.6) Sulindac is also a new NSAI drug belonging to the category of indeneacetic acid derivatives structurally related to indomethacin, and has been widely used clinically. There was no difference in the clearance ratio of SMZ before and after sulindac infusion, as shown in Fig. 1 . This fact suggests that no interaction occurs between SMZ and sulindac at the renal level.
Mepirizole is a cationic NSAI drug belonging to the category of pyrimidinyl pyrazole derivatives, and is quite different from both ibufenac and sulindac in regard to chemical and physicochemical characteristics. As also shown in Fig. 1 , mepirizole did not interact with SMZ at the renal level. This result raises the possibility that mepirizole might not be transported by the same transport process as proposed for SMZ.12)
One of the major aims of our recent researches is to demonstrate whether or not the various NSAI drugs interact with SMZ at the renal level, and to elucidate the approximate correlation between the tubular secretory activities and the chemical structural features of NSAI drugs. Several reports and reviews on the correlation between molecular features of organic anions and the renal excretory patterns have been published.13 -15) So far, twelve NSAI drugs (eleven anionic drugs and a cationic drug) including three NSAI drugs examined in this paper have been subjected to renal clearance experiments.3 -6) The chemical structures of the NSAI drugs examined are illustrated in Chart 1. All renal clearance experiments were carried out under conditions such that SMZ excretion might be inhibited by each NSAI drug if the two drugs interact at the renal level. The date are summarized in Table IV . In order to assess the effect of NSAI drugs on the renal handling of SMZ comparatively, the degree of inhibition (degree of decrease of the clearance ratio of SMZ after NSAI drug infusion) was indicated by the symbols defined in Table II . As for the correlation between degree of inhibition of SMZ excretion and the chemical structures of anionic NSAI drugs, a few conclusions can be drawn from the results of the present study and our preceding reports') as follows. Since only one barbituric acid derivative and one indeneacetic acid derivative were tested here, additional trials will be necessary. Chart 1 It is generally agreed that certain organic anions are secreted through the proximal tubules by the PAH transport process, and competition for tubular transport of such organic anions is established as the process underlying the depression of the secretion of one compound by another.13,16) Each anionic NSAI drug might inhibit renal proximal tubular secretion of SMZ by competing with it in the anionic transport process proposed for SMZ and these NSAI drugs.
The reason why SMZ excretion was not affected by flurbiprofen is obscure. Flurbiprofen is the only compound containing fluorine among the five propionic acid derivatives examined. The introduction of fluorine into the propionic acid derivatives might affect the renal handling. Sulindac also contains fluorine in the molecular structure and dose not affect SMZ excretion. Elucidation of the correlation between the introduction of fluorine into propionic acid derivatives or indeneacetic acid derivatives and the renal handling requires more extensive study.
As mentioned above, the interactions between SMZ and the anionic NSAI drugs at the renal level were partially elucidated by means of renal clearance experiments. However, in order to obtain more precise information about the correlation between the renal secretory characteristics and the chemical structures of anionic NSAI drugs, more intensive and detailed studies using renal cortical slices or membrane vesicles isolated from the renal cortex will be necessary.
Mepirizole was the only organic cationic drug used in this study, and did not interact with SMZ at the renal level. Certain organic cations such as tetraethylammonium bromide or N-methylnicotinamide are well known to be excreted into urine by proximal tubular secretion.17,18) The organic cation transport system is clearly separated from the anion transport system.18) Competitive inhibitors of the transport of organic cations do not inhibit the transport of organic anions such as PAH. Mepirizole might be excreted into urine by a cation transport process different from the anion transport process proposed for SMZ and 
